OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors
Learn more
OnCusp Therapeutics and Multitude Therapeutics Enter into an Ex-China Licensing Agreement for a Potentially Highly Differentiated CDH6-Targeting Antibody Drug Conjugate
Learn more
Dialogue with the Co-Founders , OnCusp 1-Year Anniversary
Learn more
OnCusp: Bing Yuan’s newco to provide bridge from innovation to MNC（by BioCentury）
Learn more
Exploring new business models in the biopharmaceutical industry （by PharmCube）
Learn more
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies
Learn more
